Literature DB >> 1430332

Acetylcholinesterase reactivity in the frontal cortex of human and monkey: contribution of AChE-rich pyramidal neurons.

L Mrzljak1, P S Goldman-Rakic.   

Abstract

Light and electron microscopic histochemistry were used to analyze the distribution of the enzyme acetylcholinesterase (AChE) in the frontal cortex of macaque monkey and human. In prefrontal, premotor, prelimbic, and medial paralimbic areas, AChE reactivity showed a characteristic bilaminar appearance due to a combination of positive neuronal and fiber labeling in deep layer III and layer V. In addition, layer I contained dense AChE-reactive fiber plexuses labeled throughout the frontal areas. One of the major issues addressed in this study was whether pyramidal neurons in the nonhuman primate cortex express AChE reactivity, as has been reported for humans. Three different histochemical methods were applied to provide confidence in the reliability of the results. Light microscopic analysis revealed strongly reactive, intensely stained pyramidal neurons in monkey as well as in the human. Further, these AChE-rich neurons exhibited the same pattern of laminar and regional variation in both species. In the prefrontal and premotor areas, AChE-rich pyramidal neurons predominated in layer III. In the motor cortex, they were also concentrated in layer III, but numerous AChE-rich pyramids were observed in layer V. In contrast, medial paralimbic areas had more AChE-rich neurons in layer V than in layer III. Finally, at the electron microscopic level, the subcellular distribution of AChE histochemical product in pyramidal neurons was identical in both monkey and human. The only difference noted between the two species was that the density of AChE-rich pyramidal neurons was greater in humans than in monkeys. Since nonhuman primates possess a system of AChE-reactive pyramidal neurons similar to human, they provide a potentially useful animal model for analyzing acetylcholinesterase neuronal systems in the cortex, which are compromised in various neuropathological diseases like Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430332     DOI: 10.1002/cne.903240208

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  5 in total

Review 1.  Modulators in concert for cognition: modulator interactions in the prefrontal cortex.

Authors:  Lisa A Briand; Howard Gritton; William M Howe; Damon A Young; Martin Sarter
Journal:  Prog Neurobiol       Date:  2007-06-30       Impact factor: 11.685

2.  Tonic and phasic release of glutamate and acetylcholine neurotransmission in sub-regions of the rat prefrontal cortex using enzyme-based microelectrode arrays.

Authors:  Catherine E Mattinson; Jason J Burmeister; Jorge E Quintero; Francois Pomerleau; Peter Huettl; Greg A Gerhardt
Journal:  J Neurosci Methods       Date:  2011-08-27       Impact factor: 2.390

Review 3.  Neuroimaging studies of normal brain development and their relevance for understanding childhood neuropsychiatric disorders.

Authors:  Rachel Marsh; Andrew J Gerber; Bradley S Peterson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

Review 4.  Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence.

Authors:  Tammy T Hshieh; Tamara G Fong; Edward R Marcantonio; Sharon K Inouye
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-07       Impact factor: 6.053

5.  Ventrolateral prefrontal cortex is required for performance of a strategy implementation task but not reinforcer devaluation effects in rhesus monkeys.

Authors:  Mark G Baxter; David Gaffan; Diana A Kyriazis; Anna S Mitchell
Journal:  Eur J Neurosci       Date:  2009-05-09       Impact factor: 3.386

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.